4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001600132-16-000019
CIK 0001600132operating
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 4:03 PM ET
Size
5.3 KB
Accession
0001600132-16-000019
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2016-02-29+130,000→ 130,000 totalExercise: $2.30Exp: 2026-03-01→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 29, 2016. This option vests in four equal installments over a four-year period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 4:03 PM ET
- Size
- 5.3 KB